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Abstract
Background: Studies have highlighted the inadequacies of the public health sector in sub-Saharan African countries in
providing appropriate malaria case management. The readiness of the public health sector to provide malaria case-
management in Somalia, a country where there has been no functioning central government for almost two decades, was
investigated.
Methods: Three districts were purposively sampled in each of the two self-declared states of Puntland and Somaliland
and the south-central region of Somalia, in April-November 2007. A survey and mapping of all public and private health
service providers was undertaken. Information was recorded on services provided, types of anti-malarial drugs used and
stock, numbers and qualifications of staff, sources of financial support and presence of malaria diagnostic services, new
treatment guidelines and job aides for malaria case-management. All settlements were mapped and a semi-quantitative
approach was used to estimate their population size. Distances from settlements to public health services were
computed.
Results: There were 45 public health facilities, 227 public health professionals, and 194 private pharmacies for
approximately 0.6 million people in the three districts. The median distance to public health facilities was 6 km. 62.3% of
public health facilities prescribed the nationally recommended anti-malarial drug and 37.7% prescribed chloroquine as
first-line therapy. 66.7% of public facilities did not have in stock the recommended first-line malaria therapy. Diagnosis of
malaria using rapid diagnostic tests (RDT) or microscopy was performed routinely in over 90% of the recommended
public facilities but only 50% of these had RDT in stock at the time of survey. National treatment guidelines were available
in 31.3% of public health facilities recommended by the national strategy. Only 8.8% of the private pharmacies prescribed
artesunate plus sulphadoxine/pyrimethamine, while 53.1% prescribed chloroquine as first-line therapy. 31.4% of private
pharmacies also provided malaria diagnosis using RDT or microscopy.
Conclusion: Geographic access to public health sector is relatively low and there were major shortages of appropriate
guidelines, anti-malarials and diagnostic tests required for appropriate malaria case management. Efforts to strengthen
the readiness of the health sector in Somalia to provide malaria case management should improve availability of drugs
and diagnostic kits; provide appropriate information and training; and engage and regulate the private sector to scale up
malaria control.
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The adoption into policy since 2004 of new artemisinin-
based combination treatments (ACT) for uncomplicated
malaria has been almost universal across Africa [1]. How-
ever, there have been delays in the deployment of these
new, efficacious medicines due to concerns about sus-
tained financing, difficulties in integrating revised recom-
mendations into national standard treatment guidelines
and drug procurement and distribution to the periphery
of the health sector [2-8]. Several studies have highlighted
inadequacies of the formal public health sector to guaran-
tee appropriate levels of drugs, training and guidelines to
all their service providers several years after the introduc-
tion of new ACT drugs [7,9-11]. These studies serve as a
reminder that having recommendations for efficacious
drugs does not necessarily translate into a health system
prepared to deliver these new medicines to target patients.
Somalia revised its national malaria treatment policy in
May 2005, abandoning chloroquine as first-line treatment
for uncomplicated malaria in favour of a combination of
co-administered artesunate and sulphadoxine-pyrimeth-
amine (AS-SP) [12], which was shown to have an ade-
quate clinical and parasitological response by day 28 of
between 95% and 99% across three sites in the country
[13]. Quinine was recommended as second-line therapy
for treatment failures at both hospitals and Mother and
Child Health (MCH) facilities [12]. Diagnosis of malaria
was to be undertaken using rapid diagnostic tests (RDT)
or microscopy at all health facilities except the lower level
health posts where the use of clinical diagnosis and pre-
sumptive treatment with SP as first-line therapy was rec-
ommended. In case of treatment failure with SP at health
posts, patients are to be referred to higher-level facilities
for treatment [12].
Civil war has ravaged Somalia for over 19 years causing
untold suffering, famine and displacement of its popula-
tion. In 2000, efforts were made by the international com-
munity to support the fragile health system and work
toward a reconstruction of this sector to support the
health needs of Somali's [14]. This coordinated effort
received support from multiple international non-govern-
ment organizations, bi-lateral agencies and support from
the Global Fund for AIDS, TB and Malaria (GFATM) [15].
The Somali Aid Coordinating Body, comprised of devel-
opment partners, UNICEF, WHO and the three ministries
of health representing the three regions of Somalia,
applied for support from the GFATM during round 2 and
were awarded 12.9 million USD in 2002 to implement a
new national malaria strategy [15], including the delivery
of AS-SP as first-line treatment.
Very little is known about the current capacities of the
public and private sector health services in Somalia and
we present here the results of a rapid assessment of the
extent, coverage and readiness of services able to provide
malaria case-management in three districts.
Methods
Study sites
Three study districts were purposively sampled in consul-
tation with the respective ministries of health and guided
by the security clearance provided by the United Nations
from each of the two self-declared republics in Somalia,
(Somaliland, Puntland) and the region of south-central
Somalia. The districts included Gebiley district, 50 km
west of Hargeisa, the capital of Somaliland; Garowe/
Burtinle districts in Puntland; and Merka in south central
Somalia, bordering the Indian Ocean and 100 km south
of Mogadishu (Figure 1). The malaria ecologies vary
between these three sites ranging from exceptionally arid
and low population density areas in Garowe/Burtinle
with low malaria transmission, Gebiley district with simi-
lar arid, low malaria transmission conditions but higher
Map of Somalia showing the two self-declared states (Punt-land and Somaliland) and the south-central region; their capi-t l cities; and the study istrictsFigur  1
Map of Somalia showing the two self-declared states 
(Puntland and Somaliland) and the south-central 
region; their capital cities; and the study districts. Dis-
trict boundaries are as defined by the local authorities and 
may not match internationally recognized boundaries.Page 2 of 8
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higher malaria transmission located closer to the Shabelle
river, more intense agriculture and highest population
density [16].
Health facility and settlement mapping
A baseline digital database of boundaries, settlements,
roads and health facilities obtained from the Somalia
office of the United Nations Development Programme
(UNDP) was used to prepare initial district maps. In col-
laboration with local health authorities and elders these
district maps were further modified to represent recent
changes in the boundaries of health service provision for
the district. Consultation with district-level health manag-
ers provided additional information on known health
service providers. Field workers were selected by the
respective state ministry of health in collaboration with
the WHO local offices and were trained in the administra-
tion of survey questionnaires and use of a global position-
ing system (GPS: Garmin Etrex). Field workers were
instructed to use the preliminary maps to confirm settle-
ment locations and provisional population sizes and
position all health providers managed by NGO's, minis-
tries of health and private sector pharmacies and clinics
and record a longitude and latitude for each structure or
central position of each settlement. Provisional popula-
tion totals were obtained from the UNDP settlement data
and these were verified using household counts and dis-
cussions with village and clan elders. All assembled posi-
tional data were later overlaid on Google Earth imagery
downloaded from [17] and captured between 2005 and
2007 to triangulate GPS positions.
Each survey team comprised of two interviewers, a driver
and a locally appointed guide. In each district a total of
five teams were involved in the survey and teams were
assigned areas of relatively equal population/area. The
survey took place from the 7th – 22nd April 2007 in Gebi-
ley; 25th October – 10th November 2007 in Garowe/
Burtinle; and 30th August – 9th September 2007 in Merka.
Facility audits
Questionnaires were developed to record information on
services provided, anti-malarial drugs in stock on the day
of the survey, numbers and qualifications of staff, sources
of financial support and presence and stock of malaria
diagnostic services, new treatment guidelines and job
aides for malaria case-management at public health facil-
ity. A less detailed questionnaire for private health facili-
ties documenting the type of health facility; malaria
services provided and type of drugs used for first- and sec-
ond-line malaria treatment was also developed. Manuals
were developed prior to the survey explaining the ques-
tionnaire and providing visual imagery of drugs and sup-
porting case-management aides to assist in training and
completion of the service provider audits. At each public
and private health facility, the person in-charge at the time
of visit was interviewed. Where a facility reported to have
a microscope or rapid diagnostic tests (RDT) for malaria,
these were confirmed by observation. The availability of
trained laboratory technicians, however, was based on
interviews of the person in charge of the health facility or
pharmacy.
Data entry and quality control
At the end of the survey all the completed questionnaires
were submitted to the local WHO-RBM offices. Each ques-
tionnaire was reviewed and inconsistencies were returned
to survey teams to reconcile through follow-up visits. All
health facility questionnaires data were entered in a cus-
tomised screen with internal consistency checks devel-
oped using EpiData 3 (EpiData Association, Denmark).
Spatial coordinates of health facilities and population set-
tlements were imported into ArcGIS 9.1 (ESRI Inc., USA)
and overlaid on pre-existing boundary and road maps and
Euclidean distances from settlements, excluding the dis-
trict capitals, to public health facilities were computed.
Results
Distribution of service providers and population
Table 1 shows the numbers of identified health service
providers, population settlements and estimated popula-
tion sizes. Population densities (per Km2), population-
per-service provider and median distances from settle-
ments outside the capitals of each district to the nearest
service provider were computed (Table 1). The distribu-
tion of services and population are shown in Figures 2a–c
for each district. There were 21 public health service pro-
viders in Gebiley district; 10 in Garowe/Burtinle; 14 in
Merka district. For each public health service provider
there were, on average, 10,952 people in Gebiley; 7,300 in
Garowe/Burtinle; 21,429 in Merka; representing an over-
all ratio of one public health facility for every 11,667 peo-
ple. The median distances to public health services for
settlements excluding the district capitals were highest in
Garowe/Burtinle (24.2 km); followed by Gebiley (6.8
km); and the shortest distances to public facilities were
found in Merka (4.6 km) (Table 1).
Of the 45 public health sector providers across the three
districts, four were classified as hospitals providing in-
patient care, 18 were second level out-patient providers of
MCH services and general out-patient (OP) services, and
23 were classified as health posts that provide out-patient
care services against a minimum set of essential drugs and
staffed mainly by a single community health worker
(Table 1). A total of 227 health personnel were stationed
at the 45 health facilities and the majority were nurses
(30.8%, n = 70) or auxiliary nurses (40.1%, n = 91). Only
11 qualified doctors were providing clinical services in thePage 3 of 8
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total estimated population of 603,000 with only one doc-
tor in Gebiley district. Only five facilities were directly
supported by ministries of health, the remaining 40 were
supported by NGOs, UNICEF, WHO and through partial
cost-recovery. All public health facilities that had a micro-
scope reported to have a trained laboratory technician.
The district mapping exercise identified 194 private health
service providers, commonly referred as pharmacies, in
the study districts: 54 in Gebiley district; 53 in Garowe/
Burtinle district; and 87 in Merka district. Of these, 147
(75.8%) were pharmacies only, seven (3.6%) were phar-
macies with an attached clinic, 26 (13.4%) were pharma-
cies with an attached laboratory but without a clinic, and
13 (6.7%) were pharmacies with both clinic and labora-
tory (Table 1). Population-per-pharmacy ratios were con-
siderably higher than public sector providers with one
pharmacy for every 3,108 people. Considering the phar-
macies with clinical services as providers of out-patient
care, the private sector contributed approximately 31% of
all out-patient care facilities across the three districts.
Provision of malaria treatment services in the public sector
All public health facilities provided malaria treatment
services but only 62.3% (all hospitals and MCH/OPD and
seven health posts) reported routinely prescribing the
nationally recommended first-line anti-malarial treat-
ment, and 37.8%, of which 88% were in Gebiley district,
reported the continued prescription of chloroquine as
first-line treatment for malaria (Table 2, Additional File
1). Facilities reporting the adherence to the national first-
line therapy were highest in Garowe/Burtinle districts (n =
8, 80.0%) and lowest in Gebiley district where 15/21
(71.4%) of health facilities reported providing chloro-
quine. Quinine, the second-line therapy for malaria,
which is recommended to be used only at hospitals and
MCH-OPD facilities, was prescribed in 91% of these facil-
ities in the three districts (Table 2, Additional File 1).
Table 1: A description of population density and health service providers in three districts of Somalia in 2007
Gebiley
district
Garowe/Burtinle districts Merka district Total
Area within established district boundary (Km2) 4,228.1 19,751.6 1413.5 25,393.2
Number of settlements indentified 163 42 177 382
Estimated total population (population density 
per Km2)
230,000
(54.4)
73,000
(3.7)
300,000
(212.2)
603,000
(23.7)
Total number of public health facilities 21 10 14 45
Hospitals 1 1 2 4
MCH/OP facilities 4 7 7 18
Health posts 16 2 5 23
Population per public facility ratio 10,952 per facility 7,300 per facility 21,429 per facility 11,667 per facility
Median (min, max) distance from settlement to 
public facility outside the district capital (Km)
6.8 (0.1, 16.3) 24.2 (0.1, 45.3) 4.6 (0.1,14.4) 6.3 (0.1, 45.3)
Staff per district
Doctors 1 5 5 11
Nurses 9 26 35 70
Auxillary Nurses 15 32 44 91
Community Health Workers 15 8 9 32
Laboratory technicians 4 8 11 23
Total number of Private sector providers
Pharmacy alone 32 36 79 147
Pharmacy + laboratory 15 5 6 26
Pharmacy + clinic 5 1 2 8
Pharmacy +laboratory+ clinic 2 11 0 13
Population per pharmacy ratio 4,260 per pharmacy 1,377 per pharmacy 3,448 per pharmacy 3,108 per pharmacy
MCH/OP = Mother and Child Health/Out-patient facilityPage 4 of 8
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anti-malarial drug of AS-SP or SP in stock on the day of the
survey. Over 86% of hospitals and MCH/OP facilities had
quinine in stock for treatment failures (Table 2). Revised
national treatment guidelines, developed and distributed
in 2006 using funds from GFATM were to be distributed
only in the hospitals and MCH/OP facilities but were
available in 63.6% of these public health facilities (Table
2). Only 42.2% of facilities had job aides on the new
national treatment guidelines in the form of wall charts
(Table 2). Parasitological diagnosis, which was not recom-
mended to be used in health posts, was routinely used in
91% of hospitals and MCH/OP facilities with 54.5%
reporting the ability to perform microscopy in addition to
the use of RDTs (Table 2). However, only 11/22 (50.0%)
of hospitals and MCH/OPD facilities had any RDT in
stock at the time of survey. Thirty-seven percent of the
public health facilities charged for malaria consultation,
diagnosis or treatment; 53% of these facilities were in
Gebiley district (Additional File 1).
Private sector provision of malaria treatment
Over 30% of pharmacies provided parasitological diag-
nostic services (Table 3). 3% of pharmacies in Merka pre-
scribed AS-SP, 9% in Gebiley district and 18% in Garowe/
Burtinle district. Between 8% and 37% of district-level
pharmacists prescribed SP mono-therapy, with an average
across the districts of 9% (Table 3). Up to 53% of private
sector providers routinely prescribed chloroquine as the
first-line anti-malarial therapy. Cotecxin®, an artemisinin
mono-therapy, was available in 22 (42%) of pharmacies
in Garowe/Burtinle district and 5 (6%) of pharmacies in
Merka district, none of the pharmacies in Gebiley district
stocked Cotecxin®.
Discussion
The availability of public health services was relatively low
with only 45 public health facilities and 227 health pro-
fessionals for approximately 0.6 million people and
median distance to health facilities of 6 km. This relatively
poor access to health facilities is compounded by the gen-
erally bad public transport infrastructure in Somalia. All
the health posts (n = 23) were manned by community
health workers who had received minimal clinical train-
ing. Sixty-two percent of public health facilities prescribed
the nationally recommended first-line therapy of AS-SP
for hospital and MCH/OP and SP for health posts. Eighty-
eight percent of the health facilities that did not comply
with the national first-line treatment guidelines were in
Gebiley district of Somaliland. Importantly several public
health facilities in 2007 were still prescribing chloroquine
(38%) as first-line therapy. 67% of public facilities that
were compliant with the nationally recommended treat-
ment guidelines did not have the first-line drugs in stock
on the day of survey. Diagnosis of malaria using RDT or
microscopy was performed routinely over 90% of the
public health facilities but only half of these had RDT in
stock at the time of survey. Malaria related information
such as national treatment guidelines; and RDT wall
charts were available respectively in between 60% and
80% of the hospitals and MCH/OP facilities but dosing
wall charts for AS-SP and SP monotherapy were available
in only 42% of the target public health facilities. The pri-
vate health sector, although four times larger than public
sector in numbers of outlets, had only less than 10% pre-
scribing AS-SP as the first-line therapy and the majority
prescribed chloroquine (53%) for this purpose. Interest-
ingly over 30% of private pharmacies provided malaria
diagnosis using RDT or microscopy.
A-C Maps of study districts showing the location of public and private health facilities; and the distribution of settlements by population sizeFig re 2
A-C Maps of study districts showing the location of public and private health facilities; and the distribution of 
settlements by population size. District boundaries are as defined by the local authorities and may not match internation-
ally recognized boundaries.Page 5 of 8
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Somalia, there are a number of caveats to the results. First,
the study was undertaken in only three purposively sam-
pled districts and may not be nationally representative.
The reason for adopting a purposive sample was due the
logistical and security implications of undertaking such a
study nationally in Somalia. The selected districts, how-
ever, represent the relatively more prosperous districts in
the three study regions and the equivalent health sector
indicators are probably only similar, if not poorer, for
other districts. Second, information on training received
by the private health sector workers was not recorded. This
decision was made following advice by the local health
authorities that owners of the many, probably unlicensed,
private sector providers would interpret as 'police work'
any questions on professional qualification and might
have adverse security implications for field workers. Third,
due to logistical and time constraints, a proper investiga-
tion of the performance of health workers in the public
sector, in terms of appropriate diagnosis and treatment of
malaria, was not undertaken. As a result, of those facilities
that used the recommended anti-malarials, the propor-
tion of health workers who prescribed the appropriate
dosage was not recorded. Finally, these surveys and audits
Table 2: Combined summaries of anti-malarial services provided by the public health service providers in the three study districts in 
Somalia
Total
Hospital/MCH-OP (n = 22) HP (n = 23) All (n = 45)
Reported use of anti-malarials for first-line treatment*
AS-SP 21 (95.5%) 0 21 (46.7%)
SP 0 7 (30.4%) 7 (15.6%)
Chloroquine 1 (4.5%) 16 (69.6%) 17 (37.8%)
Reported use of anti-malarials for second-line treatment**
Never use 1 (4.5%) 14 (63.6%) 15 (33.3%
Quinine 20 (91.0%) 2 (8.7%) 22 (48.9%)
SP 1 (4.5%) 7 (30.4%) 8 (17.8%)
Nationally recommended first-line therapy in stock on day of survey*** 12 (54.5%) 3 (13.0%) 15 (33.3%)
Nationally recommended second-line therapy in stock on day of survey 19 (86.4%) 0 19 (42.2%)
Parasitological diagnosis****
None 2 (9.0%) 23 (100.0%) 25 (55.5%)
RDT 20 (91.0%) 0 20 (44.4%)
Microscopy 12 (54.5%) 0 12 (26.7%)
RDT in stock on day of survey 11 (50.0%) 0 11 (24.4%)
Revised national guidelines available at facility**** 14 (63.6%) 0 14 (31.1%)
RDT use wall charts available at facility**** 18 (81.8%) 0 18 (40.0%)
Anti-malarial dosing wall charts available at facility 18 (81.8%) 1 (4.3%) 19 (42.2%)
Charging for malaria consultation, diagnosis or treatment 8 (36.4%) 9 (39.1%) 17 (37.7%)
HP = health post; MCH/OP = Mother and Child Health/Out-patient facility; SP = sulphadoxine-pyrimethamine; AS-SP = artesunate and SP; RDT = 
rapid diagnostic test
*National treatment guidelines recommend AS-SP as first-line therapy in hospitals and MCH/OP facilities and SP at health posts.
** National treatment guidelines recommend Quinine as second-line therapy in hospitals and MCH/OP facilities. The guidelines also recommend 
that health posts refer patients to MCH/OP or hospitals in case of treatment failure with AS-SP.
***First-line drugs were considered out of stock if a hospital or MCH/OP facility did not have either AS or SP or both and if a health post did not 
have SP on the day of survey.
****National treatment guidelines recommend the use of RDT or microscopy for diagnosis of malaria at hospitals and MCH/OP while at health 
posts clinical diagnosis and presumptive treatment are recommended.Page 6 of 8
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such the results represent only a single snap-shot descrip-
tion of the status of service provision in Somalia. How-
ever, these audits are useful exercises to guide areas of
policy implementation and could serve, assuming a stabi-
lizing of the security situation, as longitudinal sites to
measure progress toward national malaria control effort.
The Somalia national malaria strategy has outlined a
series of recommendations for malaria case management
including the provision of prompt access to appropriate
treatment; provision of relevant information to health
workers for appropriate case management; the perform-
ance of malaria diagnosis using RDT or microscopy at
hospitals and MCH/OPD health facilities; and engage-
ment of the informal sector in the provision of these serv-
ices [12]. On the basis of the acceptance of the new
treatments guidelines two-thirds of the public health sec-
tor complied but any practical implementation of the pol-
icy was hampered by the widespread shortages in drugs
and diagnostic tests. There is need to expand the health
services to alleviate the long distances people are likely to
walk to access health care given the poor state of public
transport; establish efficient systems that can overcome
the severe shortages of drugs and diagnostic materials;
and improve adherence to recommended diagnosis and
prescription through in-service training and job aides
notably at the peripheral health posts which serve major-
ity of the rural communities. The national malaria strategy
should also be revisited to review the continued use of SP
at health posts given that this drug has failed and is no
longer in use in most African countries.
The service provider audit highlights the prolific nature of
the private health sector in Somalia. This scales with
recent findings from a national household sample survey
of fevers and their treatment, which documented that over
40% of children who had fever in the two weeks prior to
survey sought treatment from the private sector compared
to only 8% from the public sector [18]. There is a growing
recognition internationally of the role of the private sector
in the treatment of malaria [19,20]. In Somalia the private
sector is perhaps more sophisticated than many other set-
tings in Africa, 30% provided a combination of parasito-
logical diagnosis and anti-malarial treatment. However,
as with other settings [21] private sector providers con-
tinue to prescribe non-recommended malaria treatments.
Ministries of health and stakeholders need to create mech-
anisms to engage, support and regulate the private sector
in Somalia. Population distributions in Somaliland and
Puntland converge around main roads and intersections
where private health service providers are located for mar-
ket reasons; the less well-served sparsely distributed and
remote rural settlements populations require investments
in public health sector provision, as these will still remain
the main source of care for these communities.
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